Viewing Study NCT06216158


Ignite Creation Date: 2025-12-25 @ 12:17 AM
Ignite Modification Date: 2025-12-25 @ 10:19 PM
Study NCT ID: NCT06216158
Status: RECRUITING
Last Update Posted: 2025-12-03
First Post: 2024-01-09
Is NOT Gene Therapy: False
Has Adverse Events: False

Brief Title: Iberdomide vs. Iberdomide Plus Isatuximab Maintenance Therapy Post ASCT in Newly Diagnosed Multiple Myeloma
Sponsor: University of Heidelberg Medical Center
Organization:

Study Modules

Identification Module Status Module Sponsor Collaborators Module Oversight Module Description Module Conditions Module Design Module Arms Interventions Module Outcomes Module Eligibility Module Contacts Locations Module